微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | -1.02% | -155.43% | 63.04% | 45/51 | 0.99% | 澳洋健康 | 12.87% | 行业排名> |
| 2024-12-31 | -2.76% | -127.49% | -153.08% | 33/51 | -1.19% | 澳洋健康 | 28.53% | 行业排名> |
| 2024-09-30 | 5.2% | -34.09% | 16.07% | 15/51 | 3.32% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | 4.48% | -5.29% | 143.48% | 9/51 | 2.09% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | 1.84% | 31.43% | -81.67% | 12/51 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | 10.04% | 40.81% | 27.25% | 14/51 | 3.7% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | 7.89% | 28.5% | 66.81% | 15/51 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | 4.73% | 52.58% | 237.86% | 17/51 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | 1.4% | 66.67% | -80.36% | 27/51 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 7.13% | -72.45% | 16.12% | 27/51 | -0.62% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 6.14% | -63.71% | 98.06% | 29/51 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 3.1% | -71.95% | 269.05% | 27/51 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 0.84% | 2% | -96.75% | 30/51 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 25.88% | 44.02% | 52.96% | 6/51 | -6.68% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 16.92% | 2% | 53.12% | 8/51 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 11.05% | 93.18% | -38.51% | 12/51 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2020-12-31 | 17.97% | -22.17% | 214.16% | 16/51 | 10.95% | 阳光诺和 | 26.2% | 行业排名> |
| 2020-06-30 | 5.72% | 1171.11% | -75.23% | 14/51 | 2.48% | 金域医学 | 13.23% | 行业排名> |
| 2019-12-31 | 23.09% | 35.58% | 35.58% | 10/51 | 65.31% | 万邦医药 | 52.05% | 行业排名> |
| 2018-12-31 | 17.03% | 146.99% | 146.99% | 11/51 | -0.6% | 华大基因 | 48.52% | 行业排名> |
| 2017-12-31 | -36.24% | 2% | -8153.33% | 41/51 | 1.73% | 华大基因 | 31.24% | 行业排名> |
| 2017-06-30 | 0.45% | 2% | 2% | 27/51 | 60.47% | 阳光诺和 | 13.99% | 行业排名> |